Transfection Technologies Market worth $1.8 billion by 2028
The report "Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Global Forecast to 2028 ", is projected to reach USD 1.8 billion by 2028 from an estimated USD 1.2 billion in 2023, at a CAGR of 9.4% during the forecast period. Increasing demand for advanced therapies owing to the rising prevalence of chronic diseases, along with the increasing R&D expenditure for drug discovery and development, is also aiding the adoption of transfection technologies. However, limited transfection efficiency and stringent regulatory standards are the major restraints to market growth.
Browse 517 market data Tables and 48 Figures spread through 399 Pages and in-depth TOC on "Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Global Forecast to 2028 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/transfection-technologies-market-895.html
The kits & reagents segment accounted for the largest share by product type in the transfection technologies market in 2022.
By product type, the transfection technologies market has been further categorized kits & reagents and equipment. Kits & reagents accounted for the largest share of the transfection technologies market in 2022. The large share of this segment can be attributed to the increasing demand for high-quality reagents to transfect nucleic acids into cells. Additionally, the growing R&D activities in the biopharmaceutical industry and the increased initiatives by governments in various countries to strengthen their healthcare capabilities are supporting the growth of this market.
The viral vector-based transfection segment is expected to grow at a higher rate during the forecast period.
Based on the method, the transfection technologies market has been segmented into physical transfection, biochemical based transfection, and viral vector-based transfection. In 2022, the physical transfection segment accounted for the largest share of the transfection technologies market. However, the viral vector-based transfection segment is expected to grow at a higher growth rate during the forecast period of 2023-2028. This can be attributed to the increasing demand for advanced therapies and growing research activities in the field of life sciences and cell biology.
The therapeutic delivery segment accounted for the largest share of the application segment in the transfection technologies market in 2022.
Based on application, the transfection technologies market has been segmented into therapeutic delivery, biomedical research, protein production, and cell-based microarray. In 2022, the therapeutic delivery segment accounted for the largest share of the transfection technologies market. One of the major factors driving the growth of this segment is rising incidences of chronic and rare diseases. Additionally, the rising investments in discovering new ways to develop innovative cell-based products are driving the segment growth.
The pharmaceutical and biotechnology companies segment accounted for the largest share of the end user segment in the transfection technologies market in 2022.
Based on the end user, the transfection technologies market has been segmented into pharmaceutical and biotechnology companies, CROs and CDMOs, academic & research institutes and other end users. In 2022, pharmaceutical and biotechnology companies accounted for the largest share. This can be attributed to the increasing advancements in biopharmaceutical industries. Cell and tissue-based technologies are commonly associated with transfection technologies for cell transfection. Therefore, increasing demand for cell and gene therapy is one of the major factors driving the growth of this segment.
The North America region catered for the largest share of the transfection technologies market in 2022.
The transfection technologies market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). The North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising incidence of cancer has contributed to the demand for transfection technologies.
Key players in the transfection technologies market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Merck KGaA (Germany), Sartorius AG (Polyplus) (Germany), Lonza (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), MaxCyte (US), Revvity (US), Takara Bio Inc. (Japan), Promega Corporation (US), Danaher Corporation (US), BOC Sciences (US), RJH BIOSCIENCES (Canada), Synvolux (Netherlands), Altogen Biosciences (US), BioIVT (US), Incella GmbH (Germany), InvivoGen (France), Phoreus Biotech (US), STEMCELL Technologies (Canada), EZ Biosystems (US), OZ Biosciences (France), chemicell GmbH (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Transfection Technologies Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
